In vitro and in vivo studies identify IL-10 as a key cytokine that inh
ibits cell-mediated immunity and inflammation while promoting humoral
responses. The present review summarizes our studies regarding the abi
lity of B cells to secrete IL-10. When established lines are considere
d, the production of human IL-10 is restricted to mature B-cell lines
and correlates with Epstein-Barr Virus (EBV) expression. Accordingly,
EBV infection induces purified tonsil B lymphocytes to produce high le
vels of human IL-10, whereas viral IL-10 (encoded by EBV) remains unde
tectable. Exogenous IL-10 enhances EBV-induced B-cell growth, while a
neutralizing anti-IL-10 antibody inhibits it, suggesting that IL-10 ac
ts as an autocrine growth factor for EBV-infected B lymphocytes. Norma
l B lymphocytes secrete lower levels of human IL-10 following activati
on through B-cell receptor or CD40 antigen. While addition of exogenou
s IL-4 diminishes CD40-induced secretion of IL-10, addition of Staphyl
occocus aureus Cowan I (SAC) particles increases it. Neutralization of
endogenous IL-10 does not alter growth of CD40-activated 6 cells but
inhibits their IgG, IgA, and IgM secretion, especially when costimulat
ed with SAC particles. finally, the simultaneous blocking of both endo
genous IL-10 and IL-6 Inhibits two-thirds of the production of the thr
ee isotypes when B cells were triggered through CD40 in the presence o
f SAC particles, suggesting that IL-10 synergizes with IL-6 to sustain
differentiation of CD40-activated B lymphocytes. Overexpression of B-
cell-derived IL-10 is likely to contribute in vivo to different pathol
ogies such as B-lymphoproliferative disorders and autoimmune diseases.
(C) 1997 Academic Press, Inc.